NCT02151604View on ClinicalTrials.gov

Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 23, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

Inhalation of hyperpolarized xenon gas

The xenon gas is inhaled immediately before acquisition of an MR image to enable the lung structure to be seen.

Trial Locations (1)

OX3 7LE

Oxford University Hospitals NHS Trust, Oxford

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Oxford University Hospitals NHS Trust

OTHER

NCT02151604 - Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy | Biotech Hunter | Biotech Hunter